Sanguinarine

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Sanguinarine
Sanguinarine Structure V.1.svg
Clinical data
ATC code
  • none
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEBI
ChEMBL
ECHA InfoCard 100.017.731
Chemical and physical data
Formula C20H14NO4
Molar mass 332.09
3D model (JSmol)
 NYesY (what is this?)  (verify)

Sanguinarine is a toxic polycyclic ammonium ion. It is extracted from some plants, including the bloodroot plant, from whose taxonomic name, Sanguinaria canadensis, its name is drawn; the Mexican prickly poppy (Argemone mexicana),[1] Chelidonium majus, and Macleaya cordata.

Toxicity[edit]

Sanguinarine is a toxin that kills animal cells through its action on the Na+/K+-ATPase transmembrane protein.[2] Epidemic dropsy is a disease that results from ingesting sanguinarine.[3]

If applied to the skin, sanguinarine may cause a massive scab of dead flesh where it killed the cells where it was applied, called an eschar. For this reason, sanguinarine is termed an escharotic.[4]

Alternative medicine[edit]

Native Americans once used sanguinarine in the form of bloodroot as a medical remedy, believing it had curative properties as an emetic, respiratory aid, and for a variety of ailments.[5] In Colonial America, sanguinarine from bloodroot was used as a wart remedy. Later, in 1869, William Cook's The Phsyiomedical Dispensatory included information on the preparation and uses of sanguinarine.[6] During the 1920s and 1930s, sanguinarine was the chief component of "Pinkard's Sanguinaria Compound," a drug sold by Dr. John Henry Pinkard. Pinkard advertised the compound as "a treatment, remedy, and cure for pneumonia, coughs, weak lungs, asthma, kidney, liver, bladder, or any stomach troubles, and effective as a great blood and nerve tonic." In 1931, several samples of the compound were seized by federal officials who determined Pinkard's claims to be fraudulent. Pinkard pleaded guilty in court and accepted a fine of $25.00.[7]

More recently, sanguinarine from bloodroot has been promoted by many alternative medicine companies as a treatment or cure for cancer; however, the U.S. Food and Drug Administration warns that products containing bloodroot, or other sanguinarine-based plants, have no proven anti-cancer effects, and that they should be avoided on those grounds.[8] Indeed, oral use of such products has been associated with oral leukoplakia, a possible precursor of oral cancer.[9] In addition, the escharotic form of sanguinarine, applied to the skin for skin cancers, may leave cancerous cells alive in the skin while creating a significant scar. For this reason it is not recommended as a skin cancer treatment.[citation needed]

Biosynthesis[edit]

In plants, sanguinarine synthesis begins with 4-hydroxyphenyl-acetaldehyde and dopamine. These two compounds are combined to form norcoclaurine. Next, a methyl group is added to form N-methylcoclaurine. The enzyme CYP80B1 subsequently adds a hydroxyl group, forming 3'-hydroxy-N-methylcoclaurine. The addition of another methyl group transforms this comound into reticuline.

Notably, biosynthesis of sanguinarine up to this point is virtually identical to that of morphine. However, instead of being converted to codeinone (as in the biosynthesis of morphine), reticuline is converted to scoulerine via berberine bridge enzyme (BBE). As such, this is the commitment step in the sanguinarine pathway.[10] Although it is unknown exactly how scoulerine proceeds down the biosynthetic pathway, it is eventually converted to dihydrosanguinarine. The precursor to sanguinarine, dihydrosanguinarine is converted to the final toxin via the action of dihydrobenzophenanthridine oxidase.[11]

The biosynthesis of sanguinarine[10]

See also[edit]

  • Berberine, a plant based compound with similar chemical classification as sanguinarine
  • Chelidonine (from Snowberries)

References[edit]

  1. ^ Santos, Alfredo C.; Adkilen, Pacifica (1932). "The Alkaloids of Argemone Mexicana". Journal of the American Chemical Society. 54 (7): 2923–2924. Bibcode:1932JAChS..54.2610C. doi:10.1021/ja01346a037. 
  2. ^ Pitts, Barry J. R.; Meyerson, Laurence R. (1981). "Inhibition of Na,K-ATPase Activity and Ouabain Binding by Sanguinarine". Drug Development Research. 1 (1): 43–49. doi:10.1002/ddr.430010105. 
  3. ^ Das, M; Khanna, S. K. (1997). "Clinicoepidemiological, Toxicological, and Safety Evaluation Studies on Argemone Oil". Critical Reviews in Toxicology. 27 (3): 273–297. doi:10.3109/10408449709089896. PMID 9189656. 
  4. ^ Cienki, J. J.; Zaret, L (2010). "An Internet Misadventure: Bloodroot Salve Toxicity". The Journal of Alternative and Complementary Medicine. 16 (10): 1125–1127. doi:10.1089/acm.2010.0140. PMID 20932193. 
  5. ^ "BRIT - Native American Ethnobotany Database". herb.umd.umich.edu. Retrieved 2017-05-07. 
  6. ^ "Sanguinaria Canadensis. Blood root, Red puccoon, Red turmeric. | Henriette's Herbal Homepage". www.henriettesherbal.com. Retrieved 2017-05-07. 
  7. ^ "FDA Notices of Judgment Collection, 1908-1966". ceb.nlm.nih.gov. Retrieved 2017-05-07. 
  8. ^ Research, Center for Drug Evaluation and. "Enforcement Activities by FDA - 187 Fake Cancer". www.fda.gov. Retrieved 2017-05-07. 
  9. ^ W., Neville, Brad (2002-01-01). Oral & maxillofacial pathology. W.B. Saunders. ISBN 0721690033. OCLC 899021983. 
  10. ^ a b Alcantara, Joenel; Bird, David A.; Franceschi, Vincent R.; Facchini, Peter J. (2017-04-28). "Sanguinarine Biosynthesis Is Associated with the Endoplasmic Reticulum in Cultured Opium Poppy Cells after Elicitor Treatment". Plant Physiology. 138 (1): 173–183. doi:10.1104/pp.105.059287. ISSN 0032-0889. PMC 1104173Freely accessible. PMID 15849302. 
  11. ^ "Chelirubine, Macarpine, and Sanguinarine Biosynthesis". Recommendations on Biochemical & Organic Nomenclature, Symbols & Terminology etc. International Union of Biochemistry and Molecular Biology.